Vaccinex, Inc. Files 8-K on Shareholder Vote Matters
Ticker: VCNX · Form: 8-K · Filed: May 9, 2024 · CIK: 1205922
| Field | Detail |
|---|---|
| Company | Vaccinex, Inc. (VCNX) |
| Form Type | 8-K |
| Filed Date | May 9, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote, regulatory-filing
Related Tickers: VCNX
TL;DR
Vaccinex (VCNX) is asking shareholders to vote on key company matters.
AI Summary
On May 9, 2024, Vaccinex, Inc. filed an 8-K report detailing a submission of matters to a vote of security holders. The filing indicates that the company is seeking shareholder approval for certain corporate actions.
Why It Matters
This filing signals that Vaccinex, Inc. is engaging its shareholders in significant corporate decisions, which could impact the company's future direction and shareholder rights.
Risk Assessment
Risk Level: medium — Shareholder votes can introduce uncertainty regarding corporate governance and strategic decisions.
Key Numbers
- 001-38624 — Commission File Number (Identifies the company's SEC filings)
- 16-1603202 — IRS Employer Identification No. (Company's tax identification number)
Key Players & Entities
- Vaccinex, Inc. (company) — Registrant
- May 9, 2024 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 1895 Mount Hope Avenue, Rochester, New York 14620 (address) — Principal Executive Offices
FAQ
What specific matters are being submitted for a vote of security holders?
The filing states it is a 'Submission of Matters to a Vote of Security Holders' but does not detail the specific proposals in this initial 8-K summary.
When is the earliest event reported in this filing?
The earliest event reported is May 9, 2024.
What is Vaccinex, Inc.'s state of incorporation?
Vaccinex, Inc. is incorporated in Delaware.
What is the address of Vaccinex, Inc.'s principal executive offices?
The principal executive offices are located at 1895 Mount Hope Avenue, Rochester, New York 14620.
What is the company's standard industrial classification?
The Standard Industrial Classification is Pharmaceutical Preparations [2834].
Filing Stats: 675 words · 3 min read · ~2 pages · Grade level 12.5 · Accepted 2024-05-09 16:16:11
Key Financial Figures
- $0.0001 — ich registered Common Stock, par value $0.0001 per share VCNX Nasdaq Capital Marke
Filing Documents
- d800537d8k.htm (8-K) — 36KB
- 0001193125-24-135285.txt ( ) — 152KB
- vcnx-20240509.xsd (EX-101.SCH) — 3KB
- vcnx-20240509_lab.xml (EX-101.LAB) — 17KB
- vcnx-20240509_pre.xml (EX-101.PRE) — 11KB
- d800537d8k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. VACCINEX, INC. Date: May 9, 2024 By: /s/ Jill Sanchez Jill Sanchez Chief Financial Officer